- Home
- RMTI vs BEAT Comparison
RMTI vs BEAT Comparison
Compare RMTI & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- BEAT
- Stock Information
- Founded
- RMTI 1994
- BEAT 2015
- Country
- RMTI United States
- BEAT United States
- Employees
- RMTI N/A
- BEAT N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- RMTI Health Care
- BEAT Technology
- Exchange
- RMTI Nasdaq
- BEAT Nasdaq
- Market Cap
- RMTI 71.1M
- BEAT 65.4M
- IPO Year
- RMTI 1998
- BEAT 2021
- Fundamental
- Price
- RMTI $1.39
- BEAT $1.98
- Analyst Decision
- RMTI Strong Buy
- BEAT Buy
- Analyst Count
- RMTI 2
- BEAT 1
- Target Price
- RMTI $6.00
- BEAT $8.00
- AVG Volume (30 Days)
- RMTI 183.8K
- BEAT 72.9K
- Earning Date
- RMTI 05-13-2025
- BEAT 03-13-2025
- Dividend Yield
- RMTI N/A
- BEAT N/A
- EPS Growth
- RMTI N/A
- BEAT N/A
- EPS
- RMTI N/A
- BEAT N/A
- Revenue
- RMTI $98,917,000.00
- BEAT N/A
- Revenue This Year
- RMTI $22.58
- BEAT N/A
- Revenue Next Year
- RMTI N/A
- BEAT N/A
- P/E Ratio
- RMTI N/A
- BEAT N/A
- Revenue Growth
- RMTI 22.37
- BEAT N/A
- 52 Week Low
- RMTI $1.38
- BEAT $1.70
- 52 Week High
- RMTI $5.15
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- RMTI 35.01
- BEAT 42.23
- Support Level
- RMTI $1.49
- BEAT $2.00
- Resistance Level
- RMTI $1.86
- BEAT $2.18
- Average True Range (ATR)
- RMTI 0.11
- BEAT 0.13
- MACD
- RMTI 0.02
- BEAT -0.00
- Stochastic Oscillator
- RMTI 26.40
- BEAT 38.72
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.